Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in cancer
Lingfei Li, Mingyang Li, Qingge Jia
Pathology - Research and Practice (2023) Vol. 248, pp. 154711-154711
Closed Access | Times Cited: 10

Showing 10 citing articles:

Dendritic Cell-Based Glioblastoma Vaccines: Advances and Challenges
Zuowen Zhang, Mingchang Li, Jie Huang
IntechOpen eBooks (2025)
Closed Access
Enhanced antitumor efficacy of bispecific antibody blocking PD-L1 and LAG-3 with doxorubicin: mechanism and safety evaluation
Chenxing Zhang, Jiaxin Liu, Tiejun Gu, et al.
Breast Cancer Research and Treatment (2025)
Closed Access
Myeloid-derived suppressor cells: Implication in myeloid malignancies and immunotherapy
Sunčica Kapor, Milica Radojković, Juan F. Santibáñez
Acta Histochemica (2024) Vol. 126, Iss. 5-7, pp. 152183-152183
Closed Access | Times Cited: 2
Current status and future prospects of combined immunotherapy and epidermal growth factor receptor inhibitors in head and neck squamous cell carcinoma
Xin Tian, Hongyan Zhang, Yiman Han, et al.
Cancer Treatment Reviews (2024) Vol. 132, pp. 102864-102864
Closed Access | Times Cited: 1
The Role of MDSCs in Digestive System Tumors and Research Progress in Targeted Therapy
丽葶 黄
Advances in Clinical Medicine (2024) Vol. 14, Iss. 09, pp. 925-933
Closed Access
Metabolic landscape of clear cell renal cell carcinoma and search for metabolites predictive of drug response
Michinobu Ozawa, Sei Naito, Hideki Makinoshima, et al.
Research Square (Research Square) (2024)
Open Access
Myeloid‑derived suppressor cells as targets of emerging therapies and nanotherapies (Review)
Dileep Kumar, Victor Da Silva, Natália Lemos Chaves
Medicine International (2024) Vol. 4, Iss. 5
Open Access
Dynamic changes in monocytic myeloid-Derived suppressor cells unveil insights into acute coronary syndrome pathogenesis and therapeutic potential
Yinsheng Tan, Mingde Ren, Jie Hou, et al.
Research Square (Research Square) (2024)
Closed Access
Increased CD14+HLA-DR-/low myeloid-derived suppressor cells can be regarded as a biomarker on disease severity and response to therapy in acute coronary syndrome
Yinsheng Tan, Mingde Ren, Jie Hou, et al.
PeerJ (2024) Vol. 12, pp. e18154-e18154
Open Access
Editorial: Genetic and cellular heterogeneity in tumors
Zishan Wang, Li Ma, Juan Xu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access
Page 1

Scroll to top